Incyte Corp
(FRA:ICY)
€
55.34
1.1 (2.03%)
Market Cap: 12.55 Bil
Enterprise Value: 9.00 Bil
PE Ratio: 18.16
PB Ratio: 2.50
GF Score: 84/100 - Q1 2024 Incyte Corp Earnings Call TranscriptApr 30, 2024€48.96 (+1.85%)Earnings
- Q4 2023 Incyte Corp Earnings Call TranscriptFeb 13, 2024€54.4 (+1.99%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- Incyte Corp at Goldman Sachs Healthcare C-Suite Unscripted Conference TranscriptJan 04, 2024
- Incyte Corp to Discuss the Key Data Presentations at ASH TranscriptDec 11, 2023
- Incyte Corp at Evercore ISI HealthCONx Conference TranscriptNov 30, 2023
- Incyte Corp at Guggenheim Securities Inflammation & Immunology Conference TranscriptNov 07, 2023
- Q3 2023 Incyte Corp Earnings Call TranscriptOct 31, 2023Earnings
- Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 14, 2023
- Incyte Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 11, 2023
- Incyte Corp at Wells Fargo Healthcare Conference TranscriptSep 07, 2023
- Q2 2023 Incyte Corp Earnings Call TranscriptAug 01, 2023€57.8 (+1.16%)Earnings
- Incyte Corp at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- Incyte Corp at William Blair Growth Stock Conference TranscriptJun 06, 2023
- Incyte Corp at RBC Capital Markets Global Healthcare Conference TranscriptMay 16, 2023
- Incyte Corp at Bank of America Global Healthcare Conference TranscriptMay 10, 2023
- Q1 2023 Incyte Corp Earnings Call TranscriptMay 02, 2023€68.36 (+2.61%)Earnings
- Incyte Corp at Cowen Health Care Conference TranscriptMar 06, 2023
- Incyte Corp at Guggenheim Healthcare Talks Oncology Day TranscriptFeb 08, 2023
- Q4 2022 Incyte Corp Earnings Call TranscriptFeb 07, 2023€78.32 (+1.57%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- Incyte Corp at Goldman Sachs CEOs Unscripted Conference TranscriptJan 05, 2023
- Incyte Corp Analyst and Investor Event TranscriptDec 12, 2022
- Incyte Corp at Bank of America Biotech SMID Cap Conference TranscriptDec 07, 2022
- Incyte Corp at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- Q3 2022 Incyte Corp Earnings Call TranscriptNov 01, 2022€74.84 (+3.09%)Earnings
- Incyte Corp at Morgan Stanley Global Healthcare Conference TranscriptSep 12, 2022
- Q2 2022 Incyte Corp Earnings Call TranscriptAug 02, 2022€75.32 (-0.55%)Earnings
- Incyte Corp to Discuss Opzelura In Vitiligo FDA Approval Call TranscriptJul 19, 2022
- Incyte Corp at Goldman Sachs Global Healthcare Conference TranscriptJun 14, 2022
- Incyte Corp at RBC Capital Markets Global Healthcare Conference TranscriptMay 17, 2022
- Q1 2022 Incyte Corp Earnings Call TranscriptMay 03, 2022€72.26 (+1.46%)Earnings
- Incyte Corp at Cowen Health Care Conference (Virtual) TranscriptMar 07, 2022
- Incyte Corp at SVB Leerink Global Healthcare (Virtual) TranscriptFeb 17, 2022
- Q4 2021 Incyte Corp Earnings Call TranscriptFeb 08, 2022€61.46 (-3.06%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 10, 2022
- Incyte Corp at Goldman Sachs Healthcare CEOs Unscripted Conference: A View from the Top (Virtual) TranscriptJan 06, 2022
- Incyte Corp at Evercore ISI HealthCONx Virtual Conference TranscriptNov 30, 2021
- Incyte Corp to Discuss Highlights from Oral PD-L1 Program from SITC TranscriptNov 13, 2021
- Incyte Corp at BMO Capital Markets Biopharma Spotlight Series: Oncology (Virtual) TranscriptNov 08, 2021
- Q3 2021 Incyte Corp Earnings Call TranscriptNov 02, 2021€54.6 (-8.36%)Earnings
- Incyte Corp GVHD Update Call: Approval in cGVHD and Syndax Collaboration TranscriptSep 27, 2021
- Syndax Pharmaceuticals Inc and Incyte Corp Axatilimab Collaboration Call TranscriptSep 27, 2021
- Incyte Corp to Discuss Opzelura (ruxolitinib) Cream FDA Approval Call TranscriptSep 22, 2021
- Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 13, 2021
- Q2 2021 Incyte Corp Earnings Call TranscriptAug 03, 2021€66.16 (+1.44%)Earnings
- Incyte Corp at Guggenheim Biopharma's Next Decade Virtual Conference TranscriptJun 28, 2021
- Incyte Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- Incyte Corp Sustainability Roundtable's CEO Investor Forum TranscriptJun 07, 2021
- Incyte Corp at William Blair Growth Stock Conference (Virtual) TranscriptJun 03, 2021
- Incyte Corp at Bank of America Global Research Healthcare Conference (Virtual) TranscriptMay 13, 2021
- Q1 2021 Incyte Corp Earnings Call TranscriptMay 04, 2021€69.26 (-2.72%)Earnings
- Incyte Corp Data Highlights on Adenosine Program from AACR 2021 TranscriptApr 12, 2021
- Incyte Corp at Cowen Healthcare Conference (Virtual) TranscriptMar 03, 2021
- Q4 2020 Incyte Corp Earnings Call TranscriptFeb 09, 2021€77.27 (+2.48%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference (Virtual) TranscriptJan 11, 2021
- Incyte Corp Data Highlights from ASH 2020 TranscriptDec 07, 2020
- Incyte Corp at Evercore ISI HealthCONx Conference TranscriptDec 01, 2020
- Q3 2020 Incyte Corp Earnings Call TranscriptNov 05, 2020€77.14 (-1.25%)Earnings
- MorphoSys AG and Incyte Corp to Discuss the Unmet Need and Global Opportunities for Tafasitamab in Non-Hodgkin Lymphomas Investor Call TranscriptSep 29, 2020
- Incyte Corp at Morgan Stanley Global Healthcare Conference (Virtual) TranscriptSep 16, 2020
- Q2 2020 Incyte Corp Earnings Call TranscriptAug 04, 2020€87.25 (-4.39%)Earnings
- Incyte Corp at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) TranscriptJun 23, 2020
- Incyte Corp at JMP Securities Life Sciences Conference TranscriptJun 18, 2020
- Incyte Corp at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 09, 2020
- Incyte Corp at RBC Global Healthcare Conference TranscriptMay 19, 2020
- Q1 2020 Incyte Corp Earnings Call TranscriptMay 05, 2020€91.87 (+2.83%)Earnings
- Incyte Corporation - Pemazyre FDA Approval TranscriptApr 20, 2020
- Incyte Corp Corporate Call - Data from Phase 3 TRuE-AD Trials of Ruxolitinib Cream in Atopic Dermatitis TranscriptApr 06, 2020
- Incyte Corp at Cowen HealthCare Conference TranscriptMar 02, 2020
- Q4 2019 Incyte Corp Earnings Call TranscriptFeb 13, 2020€71.5 (+1.69%)Earnings
- Incyte Corp at JPMorgan Healthcare Conference TranscriptJan 13, 2020
- MorphoSys AG and Incyte Sign Global Collaboration and License Agreement for Tafasitamab Conference Call TranscriptJan 13, 2020
- Incyte Corp GRAVITAS-301 Call TranscriptJan 02, 2020
- Incyte Corp at Piper Jaffray Healthcare Conference TranscriptDec 04, 2019
- Incyte Corp at Credit Suisse Healthcare Conference - Scottsdale TranscriptNov 12, 2019
- Q3 2019 Incyte Corp Earnings Call TranscriptOct 29, 2019€75.4 (+7.75%)Earnings
- Incyte Corp Call to Discuss Pemigatinib Development Update from European Society for Medical Oncology TranscriptSep 27, 2019
- Incyte Corp at Bank of America Merrill Lynch Global Healthcare Conference TranscriptSep 18, 2019
- Incyte Corp at Morgan Stanley Healthcare Conference TranscriptSep 10, 2019
- Q2 2019 Incyte Corp Earnings Call TranscriptJul 30, 2019€75.78 (+7.37%)Earnings
- Zai Lab Ltd and Incyte Corp to Discuss the Collaboration and License Agreement for INCMGA0012 in Greater China Call TranscriptJul 02, 2019
- Incyte Corp Key Studies Within Its Inflammation And Autoimmunity portfolio Corporate Call TranscriptJun 17, 2019
- Incyte Corp at Goldman Sachs Global Healthcare Conference TranscriptJun 11, 2019
- Incyte Corp at RBC Capital Markets Healthcare Conference TranscriptMay 21, 2019
- Incyte Corp at UBS Global Healthcare Conference TranscriptMay 20, 2019
- Incyte Corp at Bank of America Merrill Lynch Health Care Conference TranscriptMay 14, 2019
- Q1 2019 Incyte Corp Earnings Call TranscriptApr 30, 2019€66.35 (-2.43%)Earnings
- Incyte Corp at Barclays Global Healthcare Conference TranscriptMar 13, 2019
- Incyte Corp at Cowen and Company Health Care Conference TranscriptMar 11, 2019
- Q4 2018 Incyte Corp Earnings Call TranscriptFeb 14, 2019€71.93 (-1.00%)Earnings
Incyte Corp at UBS Global Healthcare Conference Transcript
May 20, 2019 / 07:00PM GMT
Release Date Price:
€68.91
(+0.23%)
Carter Lewis Gould
UBS Investment Bank, Research Division - Large Cap Biotech Analyst
Okay. Good afternoon. My name is Carter Gould. I'm a senior biotech analyst here at UBS. Welcome to day 1 of the Global Healthcare Conference. I'm pleased to welcome Incyte to the stage. CEO and President, Hervé Hoppenot, is joining me. I also remind everyone if you'd like to ask questions through the app, please feel free. They will filter down to the iPad here and I will try to ask them. All right. Thank you very much for joining us.
HervÃ;Hoppenot
Incyte Corporation - Chairman, President & CEO
© -
Thank you for inviting me.
Carter Lewis Gould
UBS Investment Bank, Research Division - Large Cap Biotech Analyst
I don't know if you want to make some opening statements or you just begin to...
HervÃ;Hoppenot
Incyte Corporation - Chairman, President & CEO
© -
I could. Yes, if it's helpful -- I mean basically, the situation for Incyte today is based on
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)